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Edlbacher and Xeber (1) showed in 1934 that the liver enzyme named 
histidase degrades histidine to NHI, formic acid, and an unknown product 
which on further treatment with strong alkali yields glutamic acid. This 
led to the suggestion that glutamic acid is a metabolic product of histidine, 
a suggestion that was supported by the finding that glycogen was formed 
from histidine about as well as from glutamic acid (2). These findings 
did not prove that glutamic acid was one of the products of histidine me- 
tabolism, and the idea became questionable when the evidence from sub- 
sequent investigations with non-isotopic histidine (3), imidazole-N16-his- 
tidine (4), and carboxyl-C14-histidine (5) were negative or inconclusive. 
In studies on the fate of carboxyl-C14-L-histidine in the liver of rabbits 
after injection and after incubation with guinea pig liver slices, we have 
found direct evidence that glutamic acid is a major product of hi&dine 
metabolism. Another highly radioactive compound was isolated by ion 
exchange chromatography, whose properties with respect to chromatog- 
raphy and lability to alkali and acid appear to correspond to those re- 
ported for isoglutamine. Takeuchi (6) isolated and identified isoglutamine 
as a product of the action of urocanicase on urocanic acid, which was ob- 
tained by the action of another liver enzyme on histidine. The formation 
of isoglutamine as an intermediate is consistent with our finding that the 
label in the radioactive glutamic acid formed from carboxyl-C14-histidine 
is not in the a-carboxyl group, and the inference is very strong that the 
label is in the y-carboxyl group. 
Materials and Methods 
The synt,hesis of the carboxyl-CY4-L-histidine used has been described 
(7). Its specific activity was 23,000 c.p.m. per mg. 
The non-protein filtrtltes of liver were obtained as follows. The liver 
* These studies were aided by a contract between the Office of Naval Research, 
United States Navy Department, and the California Institute of Technology, Di- 
vision of Biology (WR-164-30-I). The Cl4 used in this investigation was supplied by 
the Carbide and Carbon Chemicals Corporation, Oak Ridge, Tennessee, and obtained 
on allocation from the United States Atomic Energy Commission. 
t Eli Lilly Research Fellow. 
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206 HISTIDINE CONVERSION TO GLUTAMIC ACID 
was homogenized in ice water and the protein precipitated and then 
washed with 5 per cent trichloroacetic acid, after which the combined 
original filtrate and washings were extracted with ether, evaporated to 
dryness in vaczw, and the residue taken up in 2 ml. of 1.5 N HCl. A small 
amount of insoluble material was discarded. The solution was then chro- 
matographed on Dowex 50 with three strengths of HCl as eluent ac- 
cording to the method of Stein and Moore (8). The chromatographic 
column was mater-jacketed and kept at 3-4” to minimize changes due to 
the relatively strong acid during the chromatography. The eluate was 
collected in 2 to 5 ml. fractions; 0.4 ml. aliquots of each fraction were 
neutralized and analyzed for ninhydrin-reactive material by the method 
of Moore and Stein (9) ; the radioactivity of each fraction was determined 
by means of a Geiger-Miiller end-window counter on 0.6 ml. aliquots 
dried on Tygon painted aluminum cups. 
Other details of procedure are given below with the experimental results. 
Experimental Procedure and Results 
In Vivo Experiment-20 mg. of radioactive histidine were injected into 
the ear vein of each of two rabbits and the livers were removed 40 minutes 
later in one case and 20 minutes later in the other. Figs. 1 and 2 give the 
distribution of radioactivity and ninhydrin-reactive material in the frac- 
t.ions of the eluate after chromatography of the non-protein filtrates. 
In Vitro Experiment-3 mg. of radioactive histidine were incubated in 
three beakers, each containing eight guinea pig liver slices (a total of 677 
mg. of dry weight of protein) and 4.0 ml. of Krebs-Henseleit Ringer’s 
solution (10) under 95 per cent 02 and 5 per cent CO* for 3.5 hours at 38”. 
At the end of the incubation the suspension of slices and saline was ad- 
justed to pH 5 and immersed in a boiling water bath for 15 minutes and 
filtered. The filtrate was evaporated to dryness in vacw, and chromato- 
graphed as described above. The distribution of radioactivity is shown 
in Fig. 3. 
Figs. 1, 2, and 3 show that a number of radioactive substances were re- 
solved on the ion exchange resin. The areas of the radioactive peaks 
represent the relative amounts of radiohistidine and of each of its radio- 
active conversion products, formed in the liver. The identification of 
some of these as glutamic acid and aspartic acid in the in vivo experiment 
(Figs. 1 and 2) and of glutamic acid and of what appears to be an inter- 
mediate compound in the in vitro experiment (Fig. 3) is described in the 
following sections. The percentage conversion (Table I) of the histidine 
to glutamic acid and to the intermediate compound shows that this is a 
major pathway of histidine metabolism. 
Isolation of Radioactive Glutamic Acid-The glutamic acid eluate frac- 
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A. ABRAMS AND H. BORSOOK 207 
tions shown in Figs. 1, 2, and 3 were identified by paper chromatography 
and paper electrophoresis. Coincidence of ninhydrin color and radio- 
activity indicated that the radioactivity was in the glutamic acid. Fur- 
t,her evidence that the radioactive material in these fracstions was glut,amic 
HISTIOINE 
50 100 200 
ltl5N HCL- 2.5N HCL 4 4.ON HE’+ 
ML EFFLUENT 
FIG. 1. Chromatographic analysis on Dowex 50 ion exchange resin of the non- 
protein fraction of rabbit liver 40 minutes after the injection of radiohistidine. The 
radioactivity of the eluate fractions, expressed as count’s per minute per ml., is shown 
by solid lines. The ninhydrin reactivity of the same eluate fractions, expressed as 
micromoles per ml., is shown by dash lines. The peak of the histidine radioactivity, 
not shown, was 1400 c.p.m. per ml. and 1550 c.p.m. per ml. The radioactive glutamic 
acid and radioactive histidine are indicated on the diagram. The other ninhydrin 
peaks represent free amino acids and other ninhydrin-reactive material in liver; 
the other radioactive peaks are unidentified metabolic products of the radiohistidine. 
acid was obtained by filter paper chromatography. There was only one 
ninhydrin spot. Its RF values with propanol-ammonia and with phenol- 
water were identical with those of glutamic acid run simultaneously, and 
the radioactivity coincided exactly with the ninhydrin spot. This was 
conclusively established by carrier isolations and recrystallization to con- 
stant specific activity as follows. The fractions shown in Fig. 1 (in viva 
experiment) and Fig. 3 (in vitro experiment) containing the supposed glu- 
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FIG. 2. Chromatographic analysis on Dower 50 ion exchange resin of the non- 
protein fraction of rabbit liver 20 minutes after injection of radiohistidine. The 
radioactivity of the eluate fractions is expressed as counts per minute per ml. The 
radioactive glutamic acid and aspartic acid, derived metabolically from the radio- 
histidine (not shown), are indicated. The remaining radioactive peaks are unidenti- 
fied metabolic products of the radiohistidine. - 
600- 
600 - 
100 
GLUTAMIC 
ACID 
.UTAMIC ACID 
‘RECURSOR 
HlSTlDlh iE 
It-l5NHCL- 2.5NHCL- 4.ON HGL- 
ML EFFLUENT 
FIG. 3. Chromatographic analysis on Dowex 50 ion exchange resin of the non- 
protein fraction after 3.5 hours incubation of radiohistidine with guinea pig liver 
slices, in the presence of bicarbonate-CO,. The radioactivity of the eluate fractions 
is expressed as counts per minute per ml. Radioactive glutamic acid, a glutamic 
acid precursor, and radiohistidine from which they were metabolically derived, are 
indicated on the diagram. Note that aspartic acid, which is eluted just before 
glutamic acid (see Fig. 2), was not measurably radioactive. The remaining radio- 
active peaks are unidentified metabolic products of radiohistidine. 
208 
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A. ABRAMS AND H. BORSOOK 209 
tamic acid were evaporated in vacw, to dryness, 100 mg. of non-isotopic 
glutamic acid were added in the first case and 80 mg. in the second, and 
they were recrystallized as the hydrochloride by saturation with HCl 
gas. Two recrystallizations gave specific activities of 4.4 and 4.3 c.p.m. 
per mg. in the one case and 8.8 and 8.3 c.p.m. per mg. in the second case. 
Position of Label in Glutumic Acid-A 40 mg. (4.3 c.p.m. per mg.) and a 
30 mg. (8.3 c.p.m. per mg.) sample of t,he carrier isolated 2 times recrys- 
tallized glutamic acid from the in vivo and the in vitro experiments, respec- 
tively, was t*reated with ninhydrin according to t.he method of Van Slyke 
et al. (ll), and the liberated CO*, which is derived from the cr-carboxyl 
only, was collected as RaC03 whose radioactivity was then measured. 
In the first case (the in vivo experiment) only 10 per cent of the radioac- 
TABLE I 
Distribution of Radioactivity Derived from Carboxyl-C’4-L-Histidine among Various 
Compounds of Liver Non-Protein Fraction 
-: 
$2 
u 7388 
Per cent total counts administered, found in 
a5 ,Y ;z 
compounds below 
Tissue CE y u.9 
.$fi gzf .B 
IEE $46 
Histidine “-0 ;m 
Intermediate 
compound 
Aspar- 
tic acid 
I----_ __ 
min. c.p.m. 
Italhit, liver in vivo. 40 460,000 6.4 0.09 
“ “ “ I‘ 
0.58 Not identified i 
“ 26 460,ooO Not determined 0.56 “ / 0.09 
hs. 
Guinea pig liver slices. 3.5 67,140 51 3.0 20 None 
“ “ “ “ 3.5 67,140 54 1.4 17 “ 
tivity was liberated by ninhydrin, and in the second case (the in vitro 
experiment) no radioactivity could be detected in the RaCO3, although 5 
per cent could have been measured. Quantitative recovery of the CO, 
was obtained. 
The appearance of 10 per cent of the label of the glutamic acid in the 
cu-carboxyl group in the case of the in vivo experiment was probably due 
t.o COZ fixat,ion, the radioactive CO? having arisen by decarboxylation of 
the carboxyl-labeled histidinc. ;ispartic acid was labeled to a slight ex- 
tent (see Figs. 1 and 2). This may have occurred either through Cl402 
fixation or conversion of -y-carboxyl-labeled glutamic acid. Proof that 
aspartie acid was labeled was established by rcchromatographing the 
nspurtic acid fraction from l>owex 50, which had been eluted with 1.5 N 
alit1 2.5 N HCl, on starch with 0.1 I: HCl-propanol-HJ). The radioac- 
tivity coincided exactly with t,he aspartic acid fraction. Labeled CO2 
incorporation has been shown to lead to labeling of the cr-carboxyl of 
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210 HISTIDINE CONVERSION TO GLUTAMIC ACID 
glutamic acid exclusively (12-14) ; our results in the in vivo experiment 
indicate that 90 per cent of the label was very probably in the y-carboxyl 
group. 
This is shown more clearly in the in vitro experiment. The incubation 
was carried out in the presence of 0.024 M bicarbonate and under a con- 
tinuous flow of 5 per cent CO*. This great excess of unlabeled CO2 diluted 
the U402 arising from the histidine sp greatly that no radioactivity was 
found either in the aspartic acid or in the cr-carboxyl group of glutamic 
acid. Nevertheless, the isolated glutamic acid was highly radioactive. 
As the histidine was labeled in the 1 position, the inference is strong that 
the Cl4 was at the r-COOH. Nevertheless, it must be stated that the 
last point has not been proved directly. It follows, then, that the amino 
group of histidine came off in the conversion (see below). 
Isolation of Radioactive Precursor of Glutamic Acid-Fig. 3 shows a well 
resolved fract,ion which emerges after glutamic acid, and whose radio- 
activity is exceeded only by that of histidine itself. The fraction cor- 
responding to the peak of this fraction was taken to dryness in vacua at 
room temperature, and an aliquot was chromatographed on paper in a 
saturated phenol-H20 system. The compound, detected by its radio- 
activity, had an RF of 0.55. Only one radioactive spot could be detected. 
This spot did not produce a color with ninhydrin, possibly because the 
amount was not sufficient. After treatment with NHdOH-water (1: 1) 
at 100” for 2 hours, the compound was completely converted to one with 
an Rp of 0.3 corresponding to the posit’ion of glutamic acid. On the other 
hand, standing in G N HCl for 2 days caused less than 5 per cent conver- 
sion to glutamic acid, heating in 0.6 N HCl for 1 hour at 100” caused no 
significant change, and heating in 6 N HCl for 2 hours at 100” caused about 
40 per cent conversion to glutamic acid. This behavior in acid and alkali 
corresponds to that reported for isoglutamine (6), and its Rp is close to 
that reported for glutamine (15). It is noteworthy that this compound 
was observed only in the extract from the in vitro experiment (Fig. 3); 
there was very little, if any, in the extract of liver from the whole animal 
(Figs. 1 and 2). 
DISCUSSION 
The argument that histidine was converted to glutamic acid eneymat- 
ically (and physiologically) rests on the fact that radioactive glutamic acid 
was isolated by relatively mild procedures from non-protein filtrates after 
presenting the systems studied with radiohistidine, while little or no radio- 
activity was found in the ot.her common amino acids, including aspartic 
acid. The radioactive glutamic acid could not have arisen as an artifact 
in our manipulation of the liver extracts. The radioactive compound 
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A. ABR.4MS AND H. BORSOOK 211 
which yields glutamic acid readily with alkali does so only very slowly with 
even strong acid. After the incubation the liver extracts were at no time 
above pH 5, and when they were treated with trichloroacetic acid it was 
in the cold and for a short time. 
Edlbacher (1) proposed the accompanying mechanism for the con- 
version of histidine to glutamic acid. 
OH 
CH=C-CHs-CH-COOH CH=&-CHrCH-COOH 
I I I I I 
NH N 
\c/ NH* 
--+ 
NH NH2 
o=c 
H 
GHistidine ’ I 
H 
OH 
I 
C=CH-CHr-CH-COOH 
I I 
NH NH2 
I 
o=c 
H 
I 
CO-CHn--HZ-CH-COOH CO-CHs-CHr-CH-COOH 
I I c I I 
OH NH2 NH NH2 
I 
o=c 
H 
GGlutamic acid WFormyl-L-glutamine 
Oyamada (16) proposed a fundamentally different pathway for the en- 
zymatic breakdown of histidine by liver enzymes. He isolated urocanic 
acid, cu-formyl-nL-isoglutamine, and nL-isoglutamine, and proposed that 
this was the sequence in which these substances arose from each other. 
He did not designate glutamic acid as a physiological end-product. Oya- 
mada’s scheme is given in the diagram on the following page. Edlbacher 
did propose glutamic acid as the physiological end-product, its immediate 
precursor being glutamine. Glutamic acid can arise from either gluta- 
mine or isoglutamine, and evidence is presented.here that glutamic acid 
is formed enzymatically. 
Beginning with carboxyl-C14-L-histidine, according to Edlbacher’s mech- 
anism the Cl4 would be entirely in the (u-COOH of the glutamic acid 
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212 HISTIDINE CONVERSION TO GLUTAMIC ACID 
formed, while according to Oyamada’s mechanism the Cl4 would be en- 
tirely in the r-COOH group. Our evidence supports the latter mechanism 
and definitely eliminates that proposed by Edlbacher.’ 
We have no evidence on the intermediates between histidine and iso- 
glutamine proposed by Oyamada. Nor have we determined the optical 
CH=C-CHg-CH-COOH CH=C-CH=CH-COOH 
I I I I I 
NH N NH* +NH N 
\/ \c// 
H H 
I,-Histidine Urocanic acid 
OH 
I 1 
=C-CH2-CHz-COOH 
;: I 
NH N 
\f 
H 
Oxyimidazolepropionic acid 
J. 
CO--CH-CHz-CH*--COOH 
NH ti 
\/ 
H 
Imidaeolonpropionic acid 
1 
CO-CH-CHz-CHz-COOH CO-CH-CHY-CH,-COOH 
I I I I 
NH2 NH2 +-NH* NH 
I 
o=c 
H 
nn-Isoglutamine a-Formyl-on-isoglutamine 
rotation of the glutamic acid we have found to be formed (enzymatically). 
Edlbacher isolated, after treatment of a precursor with alkali, L(+)-glu- 
tamic acid. If, as Takeuchi suggests, this precursor was m-isoglutamine, 
the resulting glutamic acid should have been the DL form. The en- 
‘The formation of a-formamidinoglutaric acid through rearrangement of an in- 
termediate product proposed by Walker and Schmidt (17), on the basis of indirect 
evidence, could also result in r-csrboxyl-labeled glutamic acid arising from car- 
boxyl-labeled histidine. 
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A. ABRAMS .4XD H. BORSOOK 213 
zymatic hydrolysis of L-isoglutamine would, presumably, give only L-glu- 
tamic acid. This point needs to be investigated. 
It remains to account for the inconclusive results obtained by D’Iorio 
and Routhillier (5). These workers injected carboxyl-C14-histidine into 
the rat and 4 and 18 hours later determined the Cl4 in the aspartic and 
glutamic acids, arginine, proline, and hydroxyproline in the carcass pro- 
teins. The label was present in all of these amino acids, most in the 
arginine, least in the aspartic acid. The authors concluded “that glutamic 
acid does not appear to be an important intermediate in histidine catabo- 
lism.” The design of their experiments was such that direct glutamic 
acid formation from hi&dine could not have been shown. The time 
elapsed after the injection of the histidine was too long, 4 and 18 hours; 
the carcass protein rather than t.he non-protein fraction of the liver was 
analyzed. All that could be seen in their experiment was the general 
transfer of Cl402 arising from the decarboxylation of the histidine, as the 
highest degree of labeling in the protein arginine shows. 
Tesar and Rittenberg (4) used imidazole-N15-histidine and did not ob- 
serve significant labeling of glutamic acid isolated from the proteins. 
They recognized that this negat,ive result could have occurred as a result 
of the rapid deamination and reamination of glutamic acid and they 
pointed out that Cl4 labeling would be more conclusive. 
I1fter this work was concluded and the present communication written, 
a report appeared by Tabor and Hayaishi (18) presenting evidence of the 
formation of L-glutamic acid from L-histidine by Pseudomonas jhorescens. 
.\s far as we are aware, there has been no demonstration previous to that 
described here of the formation of glutamic acid from histidine in mam- 
malian liver in vivo or in vitro. 
SUMMARY 
1. Radioactive glutamic acicl was isolated by mild procedures from the 
liver of animals presented with carboxyl-C14-hi&dine, in in vivo and in 
vitro experiments. The Cl4 was not in the (r-COOH group and was very 
probably in the r-COOH. This finding supports the mechanism involving 
urocanic acid, formylisoglutamine, and isoglutamine as intermediates. 
2. A radioactive metabolic product of histidine was isolated by ion ex- 
change chromatography whose properties corresponded to those of iso- 
glutamine. 
3. The rate of t.he conversion of histidine to glutamic acid indicates 
that it is a major metabolic pathway. 
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